129 related articles for article (PubMed ID: 34999590)
21. Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer.
Kadakia KC; Snyder CF; Kidwell KM; Seewald NJ; Flockhart DA; Skaar TC; Desta Z; Rae JM; Otte JL; Carpenter JS; Storniolo AM; Hayes DF; Stearns V; Henry NL
Oncologist; 2016 May; 21(5):539-46. PubMed ID: 27009936
[TBL] [Abstract][Full Text] [Related]
22. PROutine: a feasibility study assessing surveillance of electronic patient reported outcomes and adherence via smartphone app in advanced cancer.
Benze G; Nauck F; Alt-Epping B; Gianni G; Bauknecht T; Ettl J; Munte A; Kretzschmar L; Gaertner J
Ann Palliat Med; 2019 Apr; 8(2):104-111. PubMed ID: 29156896
[TBL] [Abstract][Full Text] [Related]
23. Patient-reported outcomes in ovarian cancer: are they key factors for decision making?
Hilpert F; Du Bois A
Expert Rev Anticancer Ther; 2018 Oct; 18(sup1):3-7. PubMed ID: 30223698
[TBL] [Abstract][Full Text] [Related]
24. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease-the "Breast cancer care for patients with metastatic disease" (BRE-4-MED) registry.
Stangl S; Haas K; Eichner FA; Grau A; Selig U; Ludwig T; Fehm T; Stüber T; Rashid A; Kerscher A; Bargou R; Hermann S; Arndt V; Meyer M; Wildner M; Faller H; Schrauder MG; Weigel M; Schlembach U; Heuschmann PU; Wöckel A
Pilot Feasibility Stud; 2020; 6():11. PubMed ID: 32042437
[TBL] [Abstract][Full Text] [Related]
25. Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer.
Hurvitz SA; Lalla D; Crosby RD; Mathias SD
Breast Cancer Res Treat; 2013 Dec; 142(3):603-9. PubMed ID: 24218050
[TBL] [Abstract][Full Text] [Related]
26. Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry study.
Jakob A; Zahn MO; Nusch A; Werner T; Schnell R; Frank M; Hamm N; Däßler KU; Losem C; Welslau M; Hoevel P; Potthoff K
J Bone Oncol; 2022 Apr; 33():100420. PubMed ID: 35340302
[TBL] [Abstract][Full Text] [Related]
27. The impact of hormonal treatments on quality of life of patients with metastatic breast cancer.
Costantino J
Clin Ther; 2002; 24 Suppl C():C26-42. PubMed ID: 12117073
[TBL] [Abstract][Full Text] [Related]
28. Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
Bjelic-Radisic V; Fitzal F; Knauer M; Steger G; Egle D; Greil R; Schrenk P; Balic M; Singer C; Exner R; Soelkner L; Gnant M;
BMC Cancer; 2020 May; 20(1):392. PubMed ID: 32375735
[TBL] [Abstract][Full Text] [Related]
29. A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.
Oswald LB; Arredondo B; Kadono M; Martinez-Tyson D; Meade CD; Penedo F; Antoni MH; Soliman H; Costa RLB; Jim HSL
Cancer Med; 2021 Jul; 10(14):4823-4831. PubMed ID: 34165265
[TBL] [Abstract][Full Text] [Related]
30. Cancer survivor perspectives on sharing patient-generated health data with central cancer registries.
Smith TG; Dunn ME; Levin KY; Tsakraklides SP; Mitchell SA; van de Poll-Franse LV; Ward KC; Wiggins CL; Wu XC; Hurlbert M; Aaronson NK
Qual Life Res; 2019 Nov; 28(11):2957-2967. PubMed ID: 31399859
[TBL] [Abstract][Full Text] [Related]
31. A phase II, multicenter, single-arm trial of eribulin as first- or second-line chemotherapy for HER2-negative advanced or metastatic breast cancer: evaluation of efficacy, safety, and patient-reported outcomes.
Kimura K; Iwamoto M; Tanaka S; Yamamoto D; Yoshidome K; Ogura H; Terasawa R; Matsunami N; Takahashi Y; Nitta T; Morimoto T; Fujioka H; Kawaguchi K; Uchiyama K
Cancer Chemother Pharmacol; 2018 May; 81(5):923-933. PubMed ID: 29594360
[TBL] [Abstract][Full Text] [Related]
32. Quality of life with talazoparib after platinum or multiple cytotoxic non-platinum regimens in patients with advanced breast cancer and germline BRCA1/2 mutations: patient-reported outcomes from the ABRAZO phase 2 trial.
Hurvitz SA; Quek RGW; Turner NC; Telli ML; Rugo HS; Mailliez A; Ettl J; Grischke E; Mina LA; Balmaña J; Fasching PA; Bhattacharyya H; Hannah AL; Robson ME; Wardley AM
Eur J Cancer; 2018 Nov; 104():160-168. PubMed ID: 30359909
[TBL] [Abstract][Full Text] [Related]
33. Relationship Between Quality of Life and Survival in Patients With Pancreatic and Periampullary Cancer: A Multicenter Cohort Analysis.
Mackay TM; Latenstein AEJ; Sprangers MAG; van der Geest LG; Creemers GJ; van Dieren S; de Groot JB; Groot Koerkamp B; de Hingh IH; Homs MYV; de Jong EJM; Molenaar IQ; Patijn GA; van de Poll-Franse LV; van Santvoort HC; de Vos-Geelen J; Wilmink JW; van Eijck CH; Besselink MG; van Laarhoven HWM;
J Natl Compr Canc Netw; 2020 Oct; 18(10):1354-1363. PubMed ID: 33022643
[TBL] [Abstract][Full Text] [Related]
34. Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock.
Goodwin PJ; Black JT; Bordeleau LJ; Ganz PA
J Natl Cancer Inst; 2003 Feb; 95(4):263-81. PubMed ID: 12591983
[TBL] [Abstract][Full Text] [Related]
35. Using Stakeholder Engagement to Overcome Barriers to Implementing Patient-reported Outcomes (PROs) in Cancer Care Delivery: Approaches From 3 Prospective Studies.
Stover AM; Tompkins Stricker C; Hammelef K; Henson S; Carr P; Jansen J; Deal AM; Bennett AV; Basch EM
Med Care; 2019 May; 57 Suppl 5 Suppl 1():S92-S99. PubMed ID: 30985602
[TBL] [Abstract][Full Text] [Related]
36. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
37. Trastuzumab-containing regimens for metastatic breast cancer.
Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
[TBL] [Abstract][Full Text] [Related]
38. Patient-reported outcomes in survivors of breast cancer one, three, and five years post-diagnosis: a cancer registry-based feasibility study.
Skandarajah AR; Lisy K; Ward A; Bishop J; Lacey K; Mann B; Jefford M
Qual Life Res; 2021 Feb; 30(2):385-394. PubMed ID: 32997334
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Patient-Reported Outcome Utilization Within National Clinical Trials Network Cooperative Group Radiation Oncology Trials Over the Past 2 Decades.
Howell JN; Anker CJ; Walker AJ; Dorth JA; Kharofa JR
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1151-1160. PubMed ID: 33321191
[TBL] [Abstract][Full Text] [Related]
40. Associations of baseline patient-reported outcomes with treatment outcomes in advanced gastrointestinal cancer.
van Seventer EE; Fish MG; Fosbenner K; Kanter K; Mojtahed A; Allen JN; Blaszkowsky L; Clark JW; Dubois J; Franses JW; Giantonio BJ; Goyal L; Klempner SJ; Roeland EJ; Ryan DP; Weekes CD; Mulvey T; El-Jawahri A; Horick N; Corcoran RB; Parikh AR; Nipp RD
Cancer; 2021 Feb; 127(4):619-627. PubMed ID: 33170962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
